HIV protease inhibitors represent a major advance in the treatment ofHIV infection particularly when used in combination with other antiretroviral drugs. The evidence in the accompanying New Drug Profile shows that nelfinavir and saquinavir have similar activity expressed as the concentration inhibiting 50% of viral replication (lCso) in laboratory strains… CONTINUE READING